Other Capital Market Information | 24 June 2019 17:35


Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA
/ Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation
(EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052

24.06.2019 / 17:35
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

- Share buy-back - 1st Interim Report

In the period from June 17, 2019 until and including June 21, 2019, a total
of 268,881 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.

The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:

Day of repurchase         Aggregated volume in      Weighted average share
                          number of shares          price
                                                    in EUR
17.06.2019                59,935                    67.2681
18.06.2019                91,593                    67.8108
19.06.2019                34,675                    69.7601
20.06.2019                37,074                    71.3736
21.06.2019                45,604                    70.8628

The total volume of shares repurchased within the framework of this share
buy-back in the period from June 17, 2019 until and including June 21, 2019
therefore amounts to 268,881 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., June 24, 2019


---------------------------------------------------------------------------

24.06.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

     Language:    English
     Company:     Fresenius Medical Care AG & Co. KGaA
                  Else-Kröner-Straße 1
                  61352 Bad Homburg
                  Germany
     Internet:    www.freseniusmedicalcare.com



     End of News    DGAP News Service